Meadow Creek Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.67M Buy
6,960
+3,040
+78% +$833K 0.03% 364
2019
Q2
$1.11M Sell
3,920
-7,456
-66% -$2.04M 0.02% 461
2019
Q1
$3.27M Sell
11,376
-1,520
-12% -$440K 0.07% 254
2018
Q4
$3.39M Sell
12,896
-4,832
-27% -$1.33M 0.08% 235
2018
Q3
$4.86M Sell
17,728
-21,408
-55% -$5.56M 0.1% 199
2018
Q2
$9.32M Sell
39,136
-21,440
-35% -$4.96M 0.2% 107
2018
Q1
$13.3M Buy
60,576
+11,632
+24% +$2.73M 0.29% 81
2017
Q4
$11M Buy
48,944
+20,544
+72% +$4.38M 0.24% 90
2017
Q3
$5.39M Buy
28,400
+8,384
+42% +$1.6M 0.13% 158
2017
Q2
$3.77M Buy
20,016
+7,456
+59% +$1.34M 0.09% 197
2017
Q1
$2.08M Buy
12,560
+768
+7% +$122K 0.05% 289
2016
Q4
$1.7M Buy
+11,792
New +$1.58M 0.04% 301

Other funds holding ELV

Meadow Creek Investment Management's ELV Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Elevance Health (ELV) stake by 78% in Q3 2019, buying an estimated $833K and bringing the position to 6,960 shares worth $1.67M. The position accounts for 0.03% of the portfolio, ranked #364.

Meadow Creek Investment Management first reported a position in ELV in Q4 2016 and has held it in 12 quarters since. The position peaked at $13.3M in Q1 2018. 1,015 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Meadow Creek Investment Management held 6,960 shares of Elevance Health worth $1.67M as of Q3 2019.
  • Meadow Creek Investment Management bought 3,040 Elevance Health shares in Q3 2019, an estimated $833K.
  • Elevance Health made up 0.03% of Meadow Creek Investment Management's portfolio in Q3 2019, its #364 holding.
  • Meadow Creek Investment Management first reported a position in Elevance Health in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Elevance Health position peaked at $13.3M in Q1 2018.
  • 1,015 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.